15
Participants
Start Date
October 31, 2009
Primary Completion Date
October 31, 2010
Study Completion Date
October 31, 2010
E. Coli-Encapsulated, Recombinant Modified Peanut Proteins Ara h 1, Ara h 2, and Ara h 3
Up to 7 mL solution administered rectally
Mount Sinai Medical Center, New York
Johns Hopkins University, Baltimore
Lead Sponsor
Collaborators (1)
Consortium of Food Allergy Research
OTHER
Allertein Therapeutics, LLC
INDUSTRY